In a new study, researchers discovered that the human brain has four pivotal periods when it goes through marked changes, sparking five "epochs" that last for years. The adolescent phase, for example, ...

The human brain experiences five distinct eras as we age, and each is defined by changes in our neural architecture that influence how we process information, new research shows. The brain changes ...

Two North Texas men are facing charges after allegedly plotting to invade an island off Haiti, kill all the men and turn the women and children into their sex slaves, according to the U.S. Attorney's ...

News of plots emerge as Sharaa visits Washington One plot centered around official engagement, sources say Sharaa has battled against Islamic State for years Sharaa is seeking to attract Western ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces the completion of patient enrollment ...

As the Trump administration phases out penny production, some businesses are bracing to be left a bit short-changed. NewsNation’s Xavier Walton joins “Morning in America” with a closer look at why ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...

Open-world fantasy sandbox MMORPG Pax Dei is starting to pivot towards its full release systems, it seems, and two major changes to the game are coming as a result. The first is the first step towards ...

The Federal Reserve on Wednesday cut interest rates for the first time in 2025 and released policymakers' quarterly forecast of economic conditions that shows the potential outlook for further rate ...

MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for its would-be challenger to Bristol Myers Squibb’s schizophrenia treatment ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early next year. The Danish pharma and obesity heavyweight is moving forward with ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...